Proactive Investors - Run By Investors For Investors

Luceco shines even brighter after bullish AGM update

UK consumer and overseas sales for the LED lighting specialist are going well, with margins also increasing
light bulb
Luceco is thriving again

Investors piled into LED lighting specialist Luceco PLC (LON:LUCE) after it indicated profits this year will be well ahead of market expectations.

Overseas sales continue to grow with consumer demand in the UK offsetting a subdued professional market, but abroad business is described as strong.

Luceco is also benefiting from lower costs of manufacturing and material and pricing changes brought in last year.

“The continuation of improved trading into the second quarter means that the board is now confident of delivering adjusted operating profit for 2019 materially ahead of current market expectations.”

Shares jumped 14% to 116p valuing the main market listed group at £163mln. The share price has more than trebled since the start of 2019.

In a note to clients, City broker Numis said Luceco's actions on the cost base - including the Chinese manufacturing plant, improved hedging on currencies, exiting loss making activities, power overheads - and improved, if still not buoyant, end markets ‘are leveraging through to the bottom line’.

After difficulties in 2018, ‘the strength of the recovery arguably demonstrates the quality of the underlying business’, the broker added, raising its target price for Luceco to 125p and repeating a 'buy' earing on the stock.

-- Adds broker comment --

 

View full LUCE profile View Profile

Luceco PLC Timeline

Related Articles

Electrolyser
March 19 2019
ITM Power’s first-half results in January showed the hydrogen energy solutions provider has significantly strengthened its capability to deliver larger industrial scale projects
Light fittings
August 23 2018
The group's traditional LED business is operating in a fiercely competitive environment. The group is pinning its hopes on becoming a software and services business
MRI scan
February 22 2019
In February, the firm appointed Dr Tom Oakley, a qualified radiologist and former director of NHS services at telemedicine firm Synergix Health, as the new chief executive of its trading company Feedback Medical

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use